In DepthSynthetic Biology

Genome writing project confronts technology hurdles

See allHide authors and affiliations

Science  19 May 2017:
Vol. 356, Issue 6339, pp. 673-674
DOI: 10.1126/science.356.6339.673

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

More than 250 scientists, entrepreneurs, and ethicists assembled in New York City last week to discuss Genome Project–write (GP-write), which aims to build large stretches of synthetic DNA and put them to work in cells. The still-unfunded project promises better and cheaper DNA-writing technology that could help treat and study diseases or create more sustainable food and energy sources. But questions remain about whether GP-write should pursue an original goal, championed by co-founder and futurist Andrew Hessel, of assembling the 3 billion DNA bases of the human genome. In the meantime, the initiative aims to support technology-advancing "pilot projects" that modify cells from various organisms. But technical challenges—from the cost of DNA synthesis to genetic circuit design—loom large.